UK Drugs in Lactation Advisory Service
Guidance on this new antidepressant added to the database.
General breastfeeding guidance
The risks of exposing an infant to a drug via breast milk can be minimised by both health professionals and mothers if some general principles are followed. This guidance should be followed whenever a medicine is being considered for a mother who is breastfeeding her infant, whether the medicine is prescribed or purchased over-the-counter.
It must also be stressed that the general guidance, and the information provided for individual drugs in the accompanying database, only applies to full-term, healthy infants. Additonal care must be taken, and advice sought, if the infant is pre-term or has compromised health at birth.
Enquiries from healthcare professionals can be made by contacting one of the UKDILAS centres below:
0116 258 6491
0121 424 7298
Alternatively, submit an enquiry via the online enquiry form and your query will be answered as soon as possible.
As part of the 2-yearly revison of the database, the following sections have been updated recently: